Sodium Zirconium Cyclosilicate (SZC)
Korbin and Dr Dean Wallace
Sodium Zirconium Cyclosilicate (SZC) trial for the correction of hyperkalaemia
A clinical trial of a medication in children with kidney disease that has been demonstrated to effectively control high potassium levels, or hyperkalaemia, in adult patients.
- Study opened: 2019
- Trial area: International
- First patient recruited: February 2020
- Principal Investigator: Dr Dean Walker
In the news
- February 2020: First UK child takes part in kidney research trial
